7 results

• Ocaliva Market Withdrawal To Take Final Effect on Nov. 14

  October 21, 2025

  Irvin Jackson

  The recalled liver disease drug Ocaliva will no longer be available to patients after November 14, following its rejection by the FDA over liver injury risks.

• Ocaliva Liver Side Effects Are Higher for Patients Who Didn’t Respond to Drug: Study

  October 14, 2025

  Irvin Jackson

  Patients who were unresponsive to Ocaliva treatment faced significantly increased risks of liver injury and cirrhosis, according to a study published just days after the drug's recall.

• Ocaliva Recall Issued Due to Liver Injury Risks

  September 12, 2025

  Irvin Jackson

  Intercept has announced it is removing the liver disease drug Ocaliva from the market after the FDA determined it does more harm than good.

• FDA Warns of Ocaliva Liver Injury Risks Linked to Autoimmune Disorder Drug

  December 13, 2024

  Martha Garcia

  Federal regulators warns that the autoimmune treatment Ocaliva has been linked to liver damage and failure, resulting in patient deaths and the need for transplants.

• Ocaliva Side Effects Linked to Severe Liver Injuries in Some Cirrhosis Patients: FDA Warning

  May 27, 2021

  Irvin Jackson

  The FDA has added a new warning to the liver drug Ocaliva, barring its use in patients with primary biliary cholangitis and advanced cirrhosis of the liver, due to the risk of liver failure.

• Ocaliva Dosing Problems Lead To FDA Black Box Warning

  February 2, 2018

  Irvin Jackson

  The FDA is adding a new black box label warning to labels of Ocaliva, following reports of at least 19 deaths linked to incorrect dosing and severe liver injury.

• Ocaliva Dosing Problems May Increase Liver Injury Risks, FDA Warns

  September 22, 2017

  Austin Kirk

  The FDA is warning that the liver disease drug Ocaliva has been linked to cases of severe liver injury and death when inappropriate doses have been prescribed.